JNJ Fail-to-Deliver

Johnson & Johnson (JNJ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $554.67B, listed on NYSE, employing roughly 138,100 people, carrying a beta of 0.26 to the broader market. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. Led by Joaquin Duato, public since 1943-01-02.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-04-29
Latest FTD Quantity
2.1K
Latest Price
$227.79
30-Day Avg FTD
12.7K
30-Day Total FTD
381.5K

Showing 30 days of SEC fail-to-deliver data for Johnson & Johnson.

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked JNJ fail to deliver questions

What is the latest JNJ fail-to-deliver count?
As of Apr 29, 2026, Johnson & Johnson (JNJ) fail-to-deliver quantity is 2.1K shares, with a 30-day average of 12.7K shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do JNJ FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.